Welcome to Medications.com

Bromaxefed DM RF Syrup Information

What's inside Bromaxefed DM RF Syrup

Bromaxefed DM RF Syrup Active Ingredients: brompheniramine maleate, dextromethorphan hydrobromide, pseudoephedrine hydrochloride, details.
Bromaxefed DM RF Syrup Dosages & Strengths
Strength Format Route Strength Class
Bromaxefed DM RF Syrup 4 mg-15 mg-45 mg/5 mL syrup oral 5.0 milliliter(s) OTC
Bromaxefed DM RF Syrup 4 mg-15 mg-45 mg/5 mL syrup oral 5.0 milliliter(s) OTC
Bromaxefed DM RF Syrup 4 mg-15 mg-45 mg/5 mL syrup oral 5.0 milliliter(s) OTC

Recent Bromaxefed DM RF Syrup Side Effects

Posted by medication3 over 3 years ago
I'm horrified that I ever gave this to my kids after taking some for a nagging cough myself last night. My scalp and skin ar...

Posted by jnnbastian over 3 years ago
I took two doses of this stuff in a 12 hour period. It is now 2 am and I don't think I'm ever going to sleep again.

Posted by melynn over 3 years ago
My 6 1/2 year old son is in la-la land with this medication. After only one dose his pupils are dialated, he appears to feel...


Bromaxefed DM RF Syrup Chemical Information

brompheniramine maleate - The maleate salt form of brompheniramine, an alkylamine derivative and a histamine antagonist with anticholinergic and sedative properties. Brompheniramine maleate competes with histamine for the H1 receptor. This diminishes the actions of histamine on effector cells and decreases the histamine-mediated symptoms of allergic reaction such as bronchoconstriction, vasodilation, increased capillary permeability and spasmodic contractions of gastrointestinal smooth muscle.

dextromethorphan hydrobromide

pseudoephedrine hydrochloride - The hydrochloride salt form of pseudoephedrine, a phenethylamine and an diastereomer of ephedrine with sympathomimetic property. Pseudoephedrine hydrochloride displaces norepinephrine from storage vesicles in presynaptic neurones, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors. It also has weak direct agonist activity at alpha- and beta- adrenergic receptors. Receptor stimulation results in vasoconstriction and decreases nasal and sinus congestion.





© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea